News
In dementia, problematic proteins build up in brain cells, making it harder for the cells to work effectively. Researchers ...
Berlin: Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, have announced that they have entered into an ...
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...
According to them, the vaccine can safely and effectively train the immune system to recognise and fight cancer-driving ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.
Discover key insights from Edible Garden AG's Q2 2025 earnings call: strategic shifts, private label growth, new product launches, and bullish ...
Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment ...
The data, which will be presented at the IASLC 2025 World Conference on Lung Cancer in Barcelona, builds upon earlier results presented at ASCO. The study showed a disease control rate of 93.8% at the ...
1d
TipRanks on MSNVerastem Unveils Promising VS-7375 Study Results
Verastem ( ($VSTM) ) just unveiled an announcement. On August 13, 2025, Verastem announced updated safety and efficacy data from the VS-7375 Phase ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Revolution Medicines Inc. (NASDAQ: RVMD) is one of the best upside stocks to invest in now. Earlier on July 23, Revolution ...
1d
Clinical Trials Arena on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results